SCOPUS 정보 검색 플랫폼

Volumn 109, Issue 4, 2002, Pages 489-502

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa

(5) Brunt, E R a Brooks, D J b Korczyn, A D c Montastruc, J L d Stocchi, F e

a UNIVERSITY MEDICAL CENTER GRONINGEN (Netherlands)

b HAMMERSMITH HOSPITAL (United Kingdom)

c TEL AVIV UNIVERSITY (Israel)

d UNIVERSITÉ PAUL SABATIER (France)

e SAPIENZA UNIVERSITY OF ROME (Italy)

Author keywords

Bromocriptine; Drug therapy; Parkinson's disease; Ropinirole

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TITRIMETRY; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BROMOCRIPTINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEMALE; HALLUCINATIONS; HUMANS; INDOLES; LEVODOPA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE;

EID: 0036209516 PISSN: 03009564 EISSN: None Source Type: Journal
DOI: 10.1007/s007020200040 Document Type: Article

Times cited : (62)

References (32)

1
- 0023816730
- Treatment of Parkinson's disease with pergolide: A double blind study
- (1988) Mayo Clin Proc , vol.63 , pp. 969-978
- Ahlskog, J.E.¹ Muenter, M.D.²

2
- 0008723718
- Dopamine and basal ganglia disease
- (1961) Arch Neurol , vol.4 , pp. 97-102
- Barbeau, A.¹

3
- 73049129373
- Der L-3-4-Dioxyphenylalanin (DOPA) effekt bei der parkinson-akinese
- (1961) Wien Klin Wochenschr , vol.73 , pp. 787-788
- Birkmayer, W.¹ Hornykiewicz, O.²

4
- 0023678042
- A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease
- (1988) J Neural Transm , vol.27 , Issue.SUPPL. , pp. 61-70
- Chouza, C.¹ Caamaño, J.L.² De Medina, O.³ Alijanati, R.⁴ Scaramelli, A.⁵ Romero, S.⁶

5
- 0014208039
- Aromatic amino acids and modification of parkinsonism
- (1967) N Engl J Med , vol.276 , pp. 374-379
- Cotzias, G.C.¹ Van Woert, M.H.² Schiffer, L.³

6
- 0014673226
- Modification of parkinsonism: Chronic treatment with L-dopa
- (1969) N Engl J Med , vol.280 , pp. 337-345
- Cotzias, G.C.¹ Papavasiliou, P.S.² Gellene, R.³

7
- 0021921996
- Double blind trial of pergolide for Parkinson's disease
- (1985) Neurology , vol.35 , pp. 291-295
- Diamond, S.G.¹ Markham, C.H.² Treciokas, L.J.³

8
- 0025957189
- 2 agonist
- (1991) Pharmacol Biochem Behav , vol.38 , pp. 147-154
- Eden, R.J.¹ Costall, B.² Domeney, A.M.³ Gerrard, P.A.⁴ Harvey, C.A.⁵ Kelly, M.E.⁶ Naylor, R.J.⁷ Owen, D.A.⁸ Wright, A.⁹

9
- 0023917742
- Parkinson's disease: An open label trial of pergolide in patients failing bromocriptine therapy
- (1988) J Neurol Neurosurg Psychiatry , vol.51 , pp. 529-533
- Factor, S.A.¹ Sanchez-Ramos, J.R.² Weiner, W.J.³

10
- 0000224448
- Unified Parkinson's disease rating scale
- Fahn S, Marsden CD, Calne DB, Goldstein M (eds). Macmillan Healthcare Information, Florham Park
- (1987) Recent developments in Parkinson's disease , vol.2 , pp. 153-163
- Fahn, S.¹ Elton, R.L.²

11
- 0002531252
- Dopaminergic agonists in the treatment of Parkinson's disease
- Olanow CW, Lieberman AN (eds). The Parthenon Publishing Group, Park Ridge
- (1992) The scientific basis for the treatment of Parkinson's disease , pp. 157-174
- Goetz, C.G.¹

12
- 0021874692
- Chronic agonist therapy for Parkinson's disease: A 5-year study of bromocriptine and pergolide
- (1985) Neurology , vol.35 , pp. 749-751
- Goetz, C.G.¹ Tanner, C.M.² Glantz, R.H.³ Klawans, H.⁴

13
- 0030726156
- Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
- International Pramipexole-Bromocriptine Study Group
- (1997) Neurology , vol.49 , pp. 1060-1065
- Guttman, M.¹

14
- 0003412410
- National Institute of Mental Health, Rockville
- (1976) ECDEU assessment manual for psychopharmacology , pp. 217-222
- Guy, W.¹

15
- 0026754574
- Reactive oxygen species and the central nervous system
- (1992) J Neurochem , vol.59 , pp. 1609-1623
- Halliwell, B.¹

16
- 0014082977
- Parkinsonism: Onset, progression, and mortality
- (1967) Neurology , vol.17 , pp. 427-442
- Hoehn, M.M.¹ Yahr, M.D.²

17
- 0026514953
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
- (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 181-184
- Hughes, A.J.¹ Daniel, S.E.² Kilford, L.³ Lees, A.J.⁴

18
- 0029269229
- The rationale for the use of dopamine agonists in Parkinson's disease
- (1995) Neurology , vol.45 , Issue.SUPPL. 3
- Jenner, P.¹

19
- 0003089710
- Parkinson's disease
- Bloom FE, Kupfer DJ (eds). Raven Press, New York
- (1995) Psychopharmacology, the fourth generation of progress , pp. 1479-1484
- Korczyn, A.D.¹

20
- 0033595201
- A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease
- Erratum: Neurology (1999) 53:1162
- (1999) Neurology , vol.53 , pp. 364-370
- Korczyn, A.D.¹ Brunt, E.R.² Larsen, J.P.³ Nagy, Z.⁴ Poewe, W.H.⁵ Ruggieri, S.⁶

21
- 0018415901
- Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy
- (1979) Neurology , vol.29 , pp. 1253-1260
- Lesser, R.D.¹ Fahn, S.² Snider, S.R.³ Cote, L.J.⁴ Isgreen, W.P.⁵ Barrett, R.E.⁶

22
- 0022256554
- Review: The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson's disease
- (1985) Am J Med Sci , vol.290 , pp. 102-106
- Lieberman, A.N.¹ Leibowitz, M.² Gopinathan, G.³ Walker, R.⁴ Hiesiger, E.⁵ Nelson, J.⁶ Goldstein, M.⁷

23
- 0031664919
- A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease
- (1998) Neurology , vol.51 , pp. 1057-1062
- Lieberman, A.¹ Olanow, C.W.² Sethi, K.³ Swanson, P.⁴ Waters, C.H.⁵ Fahn, S.⁶ Hurtig, H.⁷ Yahr, M.⁸

24
- 0020529675
- Lisuride in the treatment of Parkinsonism
- (1983) Eur Neurol , vol.22 , pp. 240-255
- McDonald, R.J.¹ Horowski, R.²

25
- 0028630805
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: A five-year follow-up
- (1994) J Neurol Neurosurg Psychiatry , vol.57 , pp. 1034-1038
- Montastruc, J.L.¹ Rascol, O.² Senard, J.M.³ Rascol, A.⁴

26
- 0023711041
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
- (1988) Ann Neurol , vol.24 , pp. 366-378
- Mouradian, M.M.¹ Juncos, J.L.² Fabbrini, G.³ Schlegel, J.⁴ Bartko, J.J.⁵ Chase, T.N.⁶

27
- 0027363740
- A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease
- (1993) Mov Disord , vol.8 , Issue.SUPPL. 1
- Olanow, C.W.¹

28
- 0028054876
- A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease
- (1994) Mov Disord , vol.9 , pp. 40-47
- Olanow, C.W.¹ Fahn, S.² Muenter, M.³ Klawans, H.⁴ Hurtig, H.⁵ Stern, M.⁶ Shoulson, I.⁷ Kurlan, R.⁸ Grimes, J.D.⁹ Jankovic, J.¹⁰

29
- 0028108776
- Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study
- (1994) Mov Disord , vol.9 , pp. 431-436
- Pezzoli, G.¹ Martignoni, E.² Pacchetti, C.³ Angeleri, V.A.⁴ Lamberti, P.⁵ Muratorio, A.⁶ Bonuccelli, U.⁷ De Mari, M.⁸ Foschi, N.⁹ Cossutta, E.¹⁰

30
- 0033046354
- Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: A double-blind, placebo controlled, randomised, multicentre study
- (1999) J Neurol Neurosurg Psychiatry , vol.66 , pp. 436-441
- Pinter, M.M.¹ Pogarell, O.² Oertel, W.H.³

31
- 0034682308
- A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
- (2000) N Engl J Med , vol.342 , pp. 1484-1491
- Rascol, O.¹ Brooks, D.J.² Korczyn, A.D.³ De Deyn, P.P.⁴ Clarke, C.E.⁵ Lang, A.E.⁶

32
- 0002497779
- Linear pharmacokinetics of ropinirole in patients with Parkinson's disease
- (1998) Br J Clin Pharmacol , vol.45
- Taylor, A.C.¹ Beerahee, A.² Citerone, D.R.³ Miller, A.⁴ Fuell, D.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.